🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/09/2019 | 81,00 | 81,22 | 79,84 | 80,44 | -0,75% | 1,70% | 396.900 |
| 05/09/2019 | 81,67 | 81,80 | 80,15 | 81,05 | +0,30% | 2,02% | 563.300 |
| 04/09/2019 | 82,05 | 82,35 | 79,61 | 80,81 | -0,27% | 3,34% | 763.400 |
| 03/09/2019 | 82,53 | 82,97 | 80,06 | 81,03 | -1,85% | 3,53% | 452.400 |
| 30/08/2019 | 83,14 | 84,25 | 82,40 | 82,56 | -0,21% | 2,23% | 392.900 |
| 29/08/2019 | 81,48 | 82,94 | 81,16 | 82,73 | +2,07% | 2,18% | 203.100 |
| 28/08/2019 | 79,82 | 81,61 | 79,25 | 81,05 | +1,30% | 2,96% | 261.300 |
| 27/08/2019 | 81,84 | 82,88 | 79,28 | 80,01 | -1,83% | 4,40% | 461.400 |
| 26/08/2019 | 81,11 | 81,59 | 79,87 | 81,50 | +0,98% | 2,12% | 333.700 |
| 23/08/2019 | 82,53 | 83,81 | 80,33 | 80,71 | -2,58% | 4,22% | 273.600 |
| 22/08/2019 | 83,13 | 83,27 | 81,15 | 82,85 | +0,08% | 2,55% | 286.400 |
| 21/08/2019 | 81,43 | 82,82 | 81,40 | 82,78 | +1,81% | 1,74% | 283.600 |
| 20/08/2019 | 81,76 | 82,48 | 80,69 | 81,31 | -0,62% | 2,19% | 245.400 |
| 19/08/2019 | 82,17 | 82,87 | 80,50 | 81,82 | +0,55% | 2,88% | 234.500 |
| 16/08/2019 | 80,00 | 81,83 | 79,44 | 81,37 | +2,33% | 2,99% | 357.500 |
| 15/08/2019 | 79,70 | 80,54 | 78,54 | 79,52 | +0,25% | 2,51% | 292.400 |
| 14/08/2019 | 79,12 | 80,84 | 78,67 | 79,32 | -1,05% | 2,74% | 465.900 |
| 13/08/2019 | 80,77 | 82,55 | 79,60 | 80,16 | -1,27% | 3,65% | 485.500 |
| 12/08/2019 | 81,16 | 81,50 | 80,19 | 81,19 | -0,50% | 1,61% | 379.800 |
| 09/08/2019 | 81,52 | 82,77 | 80,42 | 81,60 | -0,09% | 2,88% | 562.400 |
| 08/08/2019 | 80,14 | 81,73 | 79,93 | 81,67 | +2,23% | 2,25% | 454.600 |
| 07/08/2019 | 77,86 | 80,10 | 77,20 | 79,89 | +1,93% | 3,72% | 487.500 |
| 06/08/2019 | 79,75 | 79,75 | 76,87 | 78,38 | -0,92% | 3,61% | 586.200 |
| 05/08/2019 | 82,45 | 82,66 | 77,87 | 79,11 | -4,98% | 5,81% | 911.400 |
| 02/08/2019 | 82,88 | 83,90 | 81,25 | 83,26 | +0,23% | 3,20% | 459.100 |
| 01/08/2019 | 81,29 | 85,31 | 80,93 | 83,07 | +4,83% | 5,39% | 1.282.400 |
| 31/07/2019 | 81,89 | 83,50 | 78,62 | 79,24 | -0,36% | 5,96% | 930.000 |
| 30/07/2019 | 77,69 | 80,00 | 77,52 | 79,53 | +1,70% | 3,19% | 518.700 |
| 29/07/2019 | 77,55 | 78,36 | 75,75 | 78,20 | +0,77% | 3,37% | 454.100 |
| 26/07/2019 | 76,93 | 78,92 | 76,87 | 77,60 | +0,94% | 2,66% | 578.800 |